ConductScience.org, home

Paper34697307

Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.

Abernathy ME and 11 others. NPJ Vaccines, 2021. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope. Papers, record 34697307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34697307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
PubMed
Journal
NPJ Vaccines
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2026-04-13
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abernathy MEMorgan Ehttps://orcid.org/0000-0001-9959-7713
2Gristick HBHarry B
3Vielmetter JJost
4Keeffe JRJennifer Rhttps://orcid.org/0000-0002-5317-6398
5Gnanapragasam PNPPriyanthi N P
6Lee YEYu Ehttps://orcid.org/0000-0001-5989-326X
7Escolano AAmelia
8Gautam RRajeev
9Seaman MSMichael S
10Martin MAMalcolm Ahttps://orcid.org/0000-0002-6845-9905
11Nussenzweig MCMichel Chttps://orcid.org/0000-0003-0592-8564
12Bjorkman PJPamela Jhttps://orcid.org/0000-0002-2277-3990

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 AI100148NIAID NIH HHSUnited StatesP01AI100148PubMed and NIHNIH RePORTER
CAVD INV-002143Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)PubMedPubMed
K99 AI140770NIAID NIH HHSUnited StatesK99AI140770PubMedNIH RePORTER
R00 AI140770NIAID NIH HHSUnited StatesR00AI140770PubMedNIH RePORTER
#OPP1146996Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)PubMedPubMed
HIVRAD P01 AI100148Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)PubMedPubMed
INV-002143Gates FoundationUnited StatesPubMedPubMed
INV-002143Gates FoundationUnited StatesPubMedPubMed
P50 AI150464NIAID NIH HHSUnited StatesP50AI150464PubMed and NIHNIH RePORTER

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129775847Strategies for a multi-stage neutralizing antibody-based HIV vaccine.Curr Opin Immunol2018https://conductscience.org/library/papers/29775847PubMed
228003309Progress toward active or passive HIV-1 vaccination.J Exp Med2017https://conductscience.org/library/papers/28003309PubMed
329768174HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.Immunity2018https://conductscience.org/library/papers/29768174PubMed
431142836Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques.Nature2019https://conductscience.org/library/papers/31142836PubMed
531672916A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.Science2019https://conductscience.org/library/papers/31672916PubMed
627174988Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.Science2016https://conductscience.org/library/papers/27174988PubMed
729867235Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.Nat Med2018https://conductscience.org/library/papers/29867235PubMed
823539181Rational HIV immunogen design to target specific germline B cell receptors.Science2013https://conductscience.org/library/papers/23539181PubMed
930097292Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization.Immunity2018https://conductscience.org/library/papers/30097292PubMed
1027545891Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies.Cell Rep2016https://conductscience.org/library/papers/27545891PubMed
1124068931A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.PLoS Pathog2013https://conductscience.org/library/papers/24068931PubMed
1231866284Isolation of single HIV-1 Envelope specific B cells and antibody cloning from immunized rhesus macaques.J Immunol Methods2020https://conductscience.org/library/papers/31866284PubMed
1325296255Structure and immune recognition of trimeric pre-fusion HIV-1 Env.Nature2014https://conductscience.org/library/papers/25296255PubMed
1427168247Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.Annu Rev Immunol2016https://conductscience.org/library/papers/27168247PubMed
1527617678HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.Immunity2016https://conductscience.org/library/papers/27617678PubMed
1630076101Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.Immunity2018https://conductscience.org/library/papers/30076101PubMed
179200464Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.J Immunol1997https://conductscience.org/library/papers/9200464PubMed
1829474444Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.PLoS Pathog2018https://conductscience.org/library/papers/29474444PubMed
1926781591Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.Sci Rep2016https://conductscience.org/library/papers/26781591PubMed
2022366317Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22366317PubMed

See all 57 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn Papers
37993719Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.Nature2023https://conductscience.org/library/papers/37993719

Source PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34697307

GET https://conductscience.org/api/papers/v1/34697307/references?page=2